SUPN
NASDAQ HealthcareSupernus Pharmaceuticals, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
📊 Market Data
| Price | $50.46 |
|---|---|
| Volume | 469,779 |
| Market Cap | 2.91B |
| Beta | 0.720 |
| RSI (14-Day) | 48.7 |
| 200-Day MA | $44.61 |
| 50-Day MA | $51.18 |
| 52-Week High | $59.68 |
| 52-Week Low | $29.16 |
| Forward P/E | 11.96 |
| Price / Book | 2.73 |
🎯 Investment Strategy Scores
How SUPN scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
40/100
High dividend yield + low volatility
🚀 Moon Shot
28/100
High growth potential (high beta + oversold)
🔪 Falling Knife
24/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
70/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
48/100
Large-cap, institutional-quality stocks
Find SUPN in your text
Paste any text on the homepage — the tool will extract SUPN and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.